Article
Duty of Disclosure and Consistency Requirements for Statements to PTO and Other Government Agencies
Authors
-
- Name
- Person title
- Principal
-
- Name
- Person title
- Of Counsel
Principal Kelly Allenspach Del Dotto and Of Counsel Brian D. Coggio authored a practice note for Practical Guidance discussing the Patent and Trademark Office's (PTO) 2022 notice clarifying the duty of candor and good faith in communications with the PTO. The note discusses recent focus on the duty of disclosure and reasonable inquiry in the pharmaceutical context and provides guidance on complying with these requirements.
Read the full article at Practical Guidance.
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.